TRCT
CYT

Tower Research Capital (TRC)’s Cyteir Therapeutics, Inc. Common Stock CYT Stock Holding History

Tower Research Capital (TRC)’s Portfolio CYT Stock Details CYT Fund Activity
Upgrade to unlock
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
2023
Q4 		$9.27K Sell
2023
Q3 		$19.6K Buy
2023
Q2 		$4.44K Buy
2022
Q4 		– Sell
2022
Q3 		$11K Sell
2022
Q2 		$18K Buy
2022
Q1 		$17K Buy
2021
Q4 		$25K Buy
2021
Q3 		$7K Buy